Weide L. Zhong

Guangzhou, 510120, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 126 publications

Liquid biopsy empowers precision medicine across the full course of bladder cancer

Liquid biopsy empowers precision medicine across the full course of bladder cancer

Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]

Published: May 27, 2026

The FGFRL1-FASN axis regulates neuroendocrine lineage transdifferentiation by modulating fatty acid synthesis in AR pathway-independent prostate cancer.

The FGFRL1-FASN axis regulates neuroendocrine lineage transdifferentiation by modulating fatty acid synthesis in AR pathway-independent prostate cancer.

Journal: Cancer letters

Published: April 02, 2026

Retraction Note: Identification of a novel microRNA-mRNA regulatory biomodule in human prostate cancer.

Retraction Note: Identification of a novel microRNA-mRNA regulatory biomodule in human prostate cancer.

Journal: Cell death & disease

Published: March 06, 2026

Regulatory B cells and SIVA1-LAG3 immune suppression predict poor prognosis in prostate cancer.

Regulatory B cells and SIVA1-LAG3 immune suppression predict poor prognosis in prostate cancer.

Journal: Biomolecules & biomedicine

Published: February 25, 2026

Glycolysis reprogramming predicts poor prognosis and drives therapy resistance via CLN6 in lethal prostate cancer.

Glycolysis reprogramming predicts poor prognosis and drives therapy resistance via CLN6 in lethal prostate cancer.

Journal: Acta biochimica et biophysica Sinica

Published: January 13, 2026

Neuro-immune-related gene signatures define molecular subtypes and prognostic score in bladder cancer with SERPINE2 as a potential therapeutic target.

Neuro-immune-related gene signatures define molecular subtypes and prognostic score in bladder cancer with SERPINE2 as a potential therapeutic target.

Journal: PeerJ

Published: December 09, 2025

Prognostic Significance of PPFIA2 in Localized Prostate Cancer: Integrative Analysis and Functional Validation.

Prognostic Significance of PPFIA2 in Localized Prostate Cancer: Integrative Analysis and Functional Validation.

Journal: Anticancer research

Published: October 14, 2025

Engineering endoplasmic reticulum targeted metal-polyphenol curcumin nanomicelles for melanoma therapy.

Engineering endoplasmic reticulum targeted metal-polyphenol curcumin nanomicelles for melanoma therapy.

Journal: Journal of nanobiotechnology

Published: October 06, 2025

Exploring DNA topoisomerase II alpha in adrenocortical carcinoma through multi-omics analysis: a potential biomarker and therapeutic target.

Exploring DNA topoisomerase II alpha in adrenocortical carcinoma through multi-omics analysis: a potential biomarker and therapeutic target.

Journal: Acta biochimica et biophysica Sinica

Published: August 28, 2025

Submicron silica particles drives prostate cancer aggressiveness via lipid-metabolic reprogramming.

Submicron silica particles drives prostate cancer aggressiveness via lipid-metabolic reprogramming.

Journal: Seminars in oncology

Published: August 21, 2025

Omics integration identified CRIP2 as a key mediator of olaparib resistance in prostate cancer.

Omics integration identified CRIP2 as a key mediator of olaparib resistance in prostate cancer.

Journal: Translational andrology and urology

Published: August 01, 2025

Targeting FGFR1 enhances olaparib sensitivity via MAPK-mediated BRCA2 downregulation in mCRPC.

Targeting FGFR1 enhances olaparib sensitivity via MAPK-mediated BRCA2 downregulation in mCRPC.

Journal: Translational andrology and urology

Published: July 15, 2025

Showing 1-12 of 126

Last Updated: 09/26/2026